Related Experiment Videos
[Diagnostic and therapeutic problems in HELLP syndrome]
Insights
HELLP syndrome, a severe preeclampsia complication, presents diagnostic challenges impacting maternal and perinatal outcomes. Early hemolysis detection and prompt delivery are crucial for managing this life-threatening condition.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Critical Care Medicine
Context:
- HELLP syndrome is a severe, life-threatening complication of preeclampsia.
- Despite increased awareness, maternal and perinatal mortality rates remain high.
- Diagnostic challenges include early detection, differential diagnosis, and varying definitions.
Purpose:
- To highlight diagnostic difficulties in HELLP syndrome.
- To recommend laboratory screening for early hemolysis detection.
- To emphasize the necessity of prompt delivery for definitive management.
Summary:
- Early hemolysis detection via serum haptoglobin is recommended.
- Disseminated intravascular coagulation (DIG) is secondary; heparin and antithrombin III are contraindicated.
- While conservative measures may stabilize patients, termination of pregnancy is the only definitive cure.
Impact:
- Improved early detection of hemolysis through serum haptoglobin.
- Avoidance of potentially harmful treatments like heparin for secondary DIG.
- Recommendation for immediate delivery, often via C-section, improves perinatal outcomes.
Abstract:
The HELLP syndrome is a severe and life-threatening complication of preeclampsia. Despite obstetricians are more aware of this syndrome maternal and perinatal mortality could not be reduced during the last years. The diagnostic problems of the HELLP syndrome are early detection of the disease, problems concerning differential diagnosis to other diseases with similar symptoms, and the different definition of the HELLP syndrome itself. For early detection of hemolysis determination of serum haptoglobin should be included in laboratory screening methods. Manifestation of DIG is not a principal sign of the HELLP syndrome but reflects a secondary pathophysiological process of the primary disease. Therefore administration of heparin and antithrombin III is not indicated and may lead to induction or amplification of life-threatening bleedings in these cases. Conservative approaches have shown to improve the fetal and maternal condition in individual cases, however, termination of pregnancy is the only definitive cure for patients with HELLP-syndrome. With respect to our perinatal results (n = 84) immediate delivery, predominantly by caesarean section, is recommended after diagnosis has been confirmed.